DIFFERENTIATED APPROACH IN EVALUATING THE RESPONSE OF IMMUNE SYSTEM TO THE PRESENCE OF M.TUBERCULOSIS WITH DIFFERENT DRUG SUSCEPTIBILITY

封面

如何引用文章

全文:

详细

The purpose of the study has a comparative study of quantitative and functional state of the immune system cells in patients with infiltrative pulmonary tuberculosis, which is caused by drug-sensitive and drug-resistant disease. The study included 29 patients, of which: from 12 people the disease was caused by drug-sensitive M.tuberculosis, 17 - the causative agent had multidrug resistance and 25 healthy people. We estimated the number of T- (CD45+CD3+) and B-lymphocytes (CD45+CD19+), NK-cells (CD45+CD3CD16+CD56+), T-helper cells (CD3+CD4+), cytotoxic T cells (CD3+CD8+), γδ-T-lymphocytes (CD3brightCD4-), NKT-cells (CD3+CD16+CD56+), activated T-lymphocytes and by the expression of T-helper cells of CD25 and HLA-DR, the probability of apoptosis of CD95 expression, the number of T-reg-cells (CD3+CD4+CD127CD25+) by flow cytometry on Coulter®Epics®XL instrument (Beckman Coulter, USA). Statistical data analysis was performed using Microsoft software, USA (Office Excel 2007) and StatSoft, USA (Statistica For Windows v.6.1.). Established that infiltrative tuberculosis caused by drug-sensitive M.tuberculosis, accompanied by an increase in HLA-DR expression and decrease in CD95 on T-lymphocytes, reducing the amount of B-cells, increased number of NK-cells. Infiltrative tuberculosis caused by M.tuberculosis multidrug resistance, is characterized by the absence of reducing CD95 on T-lymphocytes, a decrease in the population of NKT cells. Immunological criterion for evaluating drug sensitivity M.tuberculosis is the absolute quantity of CD3+HLA-DR+-cells.

作者简介

O. Berdugina

Ural Research Institute of Phthisiopulmonology; Ural State Medical University

编辑信件的主要联系方式.
Email: noemail@neicon.ru
俄罗斯联邦

A. Ershova

Ural Research Institute of Phthisiopulmonology

Email: noemail@neicon.ru
俄罗斯联邦

参考

  1. Warren E., Teskey G., Venketaraman V. Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection. Journal of Clinical Medicine, 2017. 6(2). 1-15.
  2. Petruccioli E., Scriba T. J., Petrone L., Hatherill M., Cirillo D. M., et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur. Respir. J., 2016. 48(6). 1751-1763.
  3. Jasenosky L. D., Scriba T. J., Hanekom W.A, Goldfeld A. E. T cells and adaptive immunity to Myco-bacterium tuberculosis in humans. Immunol Rev, 2015. 264. 74-87.
  4. Moreira-Teixeira L., Redford P. S., Stavropoulos E., Ghilardi N., Maynard C. L., et al. T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. J Immunol, 2017. 1601340.
  5. Kalo D., Kant S., Srivastava K., Sharma A. K. Assess drug resistance pattern and genetic profile of Myco-bacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS 6110 in pulmonary tuberculosis cases. Lung India, 2017. 34. 155-159.

版权所有 © Berdugina O.V., Ershova A.V., 2017

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##